Walgreens Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Portfolio Pulse from Avi Kapoor
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is set to release its Q2 earnings before the market opens on March 28, 2024, with expectations of earnings at 82 cents per share, down from $1.16 per year ago, and projected revenue of $35.86 billion. The company is also dealing with a legal action against an arbitration award of nearly $1 billion to PWNHealth. Shares rose 2.5% to $21.02 recently. Analysts have revised their ratings and price targets, with Morgan Stanley cutting its price target from $22 to $21.
March 28, 2024 | 6:36 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Walgreens is expected to report lower earnings per share compared to last year and is involved in a significant legal battle, yet shares have recently increased. Analysts have revised their price targets downwards.
The expected decrease in earnings per share indicates potential challenges, but the recent share price increase suggests some market optimism. The legal battle could introduce volatility. Analysts' downward revisions in price targets reflect caution, potentially limiting short-term upside.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100